Results 121 to 130 of about 195,293 (269)

FP486CHARACTERIZATION OF THE TRANSCRIPTOMIC PROFILE OF PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH) TREATED WITH LOW-DENSITY LIPOPROTEIN-APHERESIS (LDL-A) [PDF]

, 2015
Simona Simone, Annarita Chieti, Nicla Campobasso, Marica Strippoli, Giuseppe Grandaliano, Matteo Accetturo, Paola Pontrelli, Loreto Gesualdo, Giovanni Pertosa   +8 more
openalex   +1 more source

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia

Vascular Health and Risk Management, 2014
Alpo Vuorio,1,2 Matti J Tikkanen,3 Petri T Kovanen4 1Health Center Mehiläinen, Vantaa, Finland; 2Finnish Institute of Occupational Health, Lappeenranta, Finland; 3Heart and Lung Center, Helsinki University Central Hospital, Folkhälsan Research ...
Vuorio A, Tikkanen MJ, Kovanen PT
doaj  

Long-term (14 years) Effect of LDL Apheresis on Obstructive Changes in Aortocoronary Saphenous-vein Bypass Grafts in a Case of Heterozygous Familial Hypercholesterolemia with the LDL Receptor Proline664 to Leucine Mutation.

, 2000
Kazuo Takahashi, Junji Kobayashi, Hideaki Brno, Mariko Takahashi, Kouichi Taira, Kentaro Kaneko, Jun Tashiro, Masaki Shinomiya, Akira Miyazaki, Yasushi Saitō   +9 more
openalex   +2 more sources

Familial hypercholesterolaemia: challenges in primary care [PDF]

, 2015
Familial hypercholesterolaemia remains largely unrecognised and undertreated in Australian primary care. A new approach involving increased awareness, early detection, lifelong treatment and cascade testing of relatives is essential to improve outcomes ...
Arnold-Reed, Diane, Bell, Damon A, Brett, Tom, Garton-Smith, Jacquie, Pang, Jing, Vickery, Alistair W, Watts, Gerald F   +6 more
core   +1 more source

Serum Lipid Peroxides Level as a Risk Factor in Male Patients with Coronary Artery Diseases [PDF]

Background & Objectives: Lipid peroxidation has recently attracted considerable attention. It has been linked to carcinogenesis, aging and variety of other diseases including atherosclerosis.
رهباني نوبر, محمد, علی پناه مقدم, رضا   +1 more
core  

LDL-apheresis to decrease sFlt-1 during early severe preeclampsia: Report of two cases from a discontinued phase II trial.

European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2018
B. Haddad, G. Lefèvre, A. Rousseau, Thomas Robert, S. Saheb, C. Rafat, M. Bornes, Camille Petit-Hoang, F. Richard, E. Lecarpentier, V. Tsatsaris, J. Guibourdenche, A. Corchia, E. Rondeau, T. Simon, A. Hertig   +15 more
semanticscholar   +1 more source

Clinical Findings of Long-Term Treatment with LDL-Apheresis

, 1989
Masaki Shinomiya, Tetsuto Kanzaki, Kohji Shirai, Yasushi Saito, Sho Yoshida, Ken Takeda, Yoshiaki Inagaki, Yoichiro Tabata, Mlchio OTAKA, Yuji Ohkubo, T Itaya, Michitaka Yamashita, Hiroshi Murayama, Hitoshi OHSHIMA, Yoshihiro Hattori, Toyohiko Yoshida, Yasufumi Irie   +16 more
openalex   +2 more sources

The discovery of PCSK9 inhibitors: A tale of creativity and multifaceted translational research. [PDF]

, 2013
Elguindy, A, Yacoub, MH
core   +1 more source

Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis. [PDF]

J Clin Apher, 2019
Szymanski JM, Waldman M, Conry-Cantilena C, West KA.   +3 more
europepmc   +1 more source

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

Medical Devices: Evidence and Research, 2016
Ulrich Julius Lipidology and Center for Extracorporeal Therapy, Department for Internal Medicine III, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany Abstract: This review reports the current situation ...
Julius U
doaj